# Getty Images Holdings, Inc.: financial statements, quarterly

GETY · OTC · CIK 1898496 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gety.md) · [Financials](/companies/gety/financials.md) · [Filings](/companies/gety/filings.md) · [Insiders](/companies/gety/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gety/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [229](/filings/0001628280-24-046441.md) | [226 d](/filings/0001628280-26-018160.md) | [222](/filings/0001628280-25-024748.md) | [229](/filings/0001628280-25-039595.md) | [241](/filings/0001628280-25-051077.md) | [247 d](/filings/0001628280-26-018160.md) | [224](/filings/0001628280-26-033481.md) | [235](/filings/0001628280-26-055246.md) | [240](/filings/0001628280-25-051077.md) | [282 d](/filings/0001628280-26-018160.md) | [227](/filings/0001628280-26-033481.md) | [229](/filings/0001628280-26-055246.md) |
| Cost of revenue | $m | [60.9](/filings/0001628280-24-046441.md) | [62.7 d](/filings/0001628280-26-018160.md) | [60.3](/filings/0001628280-25-024748.md) | [63.1](/filings/0001628280-25-039595.md) | [64.1](/filings/0001628280-25-051077.md) | [65.6 d](/filings/0001628280-26-018160.md) | [60.2](/filings/0001628280-26-033481.md) | [65.6](/filings/0001628280-26-055246.md) | [64.3](/filings/0001628280-25-051077.md) | [71.2 d](/filings/0001628280-26-018160.md) | [66.2](/filings/0001628280-26-033481.md) | [68.3](/filings/0001628280-26-055246.md) |
| Selling, general and administrative | $m | [97.3](/filings/0001628280-24-046441.md) | [102 d](/filings/0001628280-26-018160.md) | [101](/filings/0001628280-25-024748.md) | [101](/filings/0001628280-25-039595.md) | [100](/filings/0001628280-25-051077.md) | [105 d](/filings/0001628280-26-018160.md) | [98.3](/filings/0001628280-26-033481.md) | [105](/filings/0001628280-26-055246.md) | [101](/filings/0001628280-25-051077.md) | [112 d](/filings/0001628280-26-018160.md) | [102](/filings/0001628280-26-033481.md) | [101](/filings/0001628280-26-055246.md) |
| Operating income | $m | [3.9](/filings/0001628280-24-046441.md) | [40.8 d](/filings/0001628280-26-018160.md) | [41.0](/filings/0001628280-25-024748.md) | [46.5](/filings/0001628280-25-039595.md) | [57.4](/filings/0001628280-25-051077.md) | [35.9 d](/filings/0001628280-26-018160.md) | [27.3](/filings/0001628280-26-033481.md) | [35.6](/filings/0001628280-26-055246.md) | [45.1](/filings/0001628280-25-051077.md) | [(24.1) d](/filings/0001628280-26-018160.md) | [31.6](/filings/0001628280-26-033481.md) | [32.4](/filings/0001628280-26-055246.md) |
| Interest expense | $m | [32.3](/filings/0001628280-23-038961.md) | [32.4 d](/filings/0001628280-24-011316.md) | [32.7](/filings/0001628280-24-022320.md) | [33.9](/filings/0001628280-25-039595.md) | [34.0](/filings/0001628280-25-051077.md) | [30.8 d](/filings/0001628280-26-018160.md) | [32.7](/filings/0001628280-26-033481.md) | [36.6](/filings/0001628280-26-055246.md) | [35.7](/filings/0001628280-25-051077.md) | [51.2 d](/filings/0001628280-26-018160.md) | [54.2](/filings/0001628280-26-033481.md) | [57.3](/filings/0001628280-26-055246.md) |
| Income tax | $m | [5.4](/filings/0001628280-24-046441.md) | [(58.0) d](/filings/0001628280-26-018160.md) | [11.2](/filings/0001628280-25-024748.md) | [12.5](/filings/0001628280-25-039595.md) | [(1.2)](/filings/0001628280-25-051077.md) | [25.0 d](/filings/0001628280-26-018160.md) | [64.6](/filings/0001628280-26-033481.md) | [(23.3)](/filings/0001628280-26-055246.md) | [(10.1)](/filings/0001628280-25-051077.md) | [12.7 d](/filings/0001628280-26-018160.md) | [2.6](/filings/0001628280-26-033481.md) | [73.4](/filings/0001628280-26-055246.md) |
| Net income | $m | [(18.4)](/filings/0001628280-24-046441.md) | [39.1 d](/filings/0001628280-26-018160.md) | [13.6](/filings/0001628280-25-051077.md) | [3.7](/filings/0001628280-25-051077.md) | [(2.5)](/filings/0001628280-25-051077.md) | [24.7 d](/filings/0001628280-26-018160.md) | [(103)](/filings/0001628280-25-051077.md) | [(34.4)](/filings/0001628280-25-051077.md) | [21.6](/filings/0001628280-25-051077.md) | [(90.9) d](/filings/0001628280-26-018160.md) | [(4.4)](/filings/0001628280-26-055246.md) | [(85.8)](/filings/0001628280-26-055246.md) |
| Diluted EPS | $ per share | [(0.05)](/filings/0001628280-24-046441.md) | not reported | [0.03](/filings/0001628280-25-024748.md) | [0.01](/filings/0001628280-25-039595.md) | [(0.01)](/filings/0001628280-25-051077.md) | not reported | [(0.25)](/filings/0001628280-26-033481.md) | [(0.08)](/filings/0001628280-26-055246.md) | [0.05](/filings/0001628280-25-051077.md) | not reported | [(0.01)](/filings/0001628280-26-033481.md) | [(0.21)](/filings/0001628280-26-055246.md) |
| Basic EPS | $ per share | [(0.05)](/filings/0001628280-24-046441.md) | not reported | [0.03](/filings/0001628280-25-024748.md) | [0.01](/filings/0001628280-25-039595.md) | [(0.01)](/filings/0001628280-25-051077.md) | not reported | [(0.25)](/filings/0001628280-26-033481.md) | [(0.08)](/filings/0001628280-26-055246.md) | [0.05](/filings/0001628280-25-051077.md) | not reported | [(0.01)](/filings/0001628280-26-033481.md) | [(0.21)](/filings/0001628280-26-055246.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [114](/filings/0001628280-23-038961.md) | [137](/filings/0001628280-25-013103.md) | [134](/filings/0001628280-24-022320.md) | [122](/filings/0001628280-24-036346.md) | [110](/filings/0001628280-24-046441.md) | [121](/filings/0001628280-26-018160.md) | [115](/filings/0001628280-25-024748.md) | [110](/filings/0001628280-25-039595.md) | [110](/filings/0001628280-25-051077.md) | [90.2](/filings/0001628280-26-055246.md) | [96.6](/filings/0001628280-26-033481.md) | [51.6](/filings/0001628280-26-055246.md) |
| Current assets | $m | [341](/filings/0001628280-23-038961.md) | [365](/filings/0001628280-25-013103.md) | [364](/filings/0001628280-24-022320.md) | [330](/filings/0001628280-24-036346.md) | [336](/filings/0001628280-24-046441.md) | [359](/filings/0001628280-26-018160.md) | [350](/filings/0001628280-25-024748.md) | [349](/filings/0001628280-25-039595.md) | [355](/filings/0001628280-25-051077.md) | [1,011](/filings/0001628280-26-055246.md) | [1,003](/filings/0001628280-26-033481.md) | [908](/filings/0001628280-26-055246.md) |
| Total assets | $m | [2,505](/filings/0001628280-23-038961.md) | [2,602](/filings/0001628280-25-013103.md) | [2,585](/filings/0001628280-24-022320.md) | [2,567](/filings/0001628280-24-036346.md) | [2,585](/filings/0001628280-24-046441.md) | [2,564](/filings/0001628280-26-018160.md) | [2,567](/filings/0001628280-25-024748.md) | [2,596](/filings/0001628280-25-039595.md) | [2,595](/filings/0001628280-25-051077.md) | [3,240](/filings/0001628280-26-055246.md) | [3,217](/filings/0001628280-26-033481.md) | [3,057](/filings/0001628280-26-055246.md) |
| Current liabilities | $m | [408](/filings/0001628280-23-038961.md) | [432](/filings/0001628280-25-013103.md) | [422](/filings/0001628280-24-022320.md) | [426](/filings/0001628280-24-036346.md) | [427](/filings/0001628280-24-046441.md) | [453](/filings/0001628280-26-018160.md) | [488](/filings/0001628280-25-024748.md) | [500](/filings/0001628280-25-039595.md) | [503](/filings/0001628280-25-051077.md) | [1,308](/filings/0001628280-26-055246.md) | [1,325](/filings/0001628280-26-033481.md) | [1,161](/filings/0001628280-26-055246.md) |
| Total liabilities | $m | [1,897](/filings/0001628280-23-038961.md) | [1,920](/filings/0001628280-25-013103.md) | [1,896](/filings/0001628280-24-022320.md) | [1,864](/filings/0001628280-24-036346.md) | [1,854](/filings/0001628280-24-046441.md) | [1,845](/filings/0001628280-26-018160.md) | [1,925](/filings/0001628280-25-024748.md) | [1,936](/filings/0001628280-25-039595.md) | [1,912](/filings/0001628280-25-051077.md) | [2,640](/filings/0001628280-26-055246.md) | [2,631](/filings/0001628280-26-033481.md) | [2,558](/filings/0001628280-26-055246.md) |
| Long-term debt | $m | [1,380](/filings/0001628280-23-038961.md) | [1,399](/filings/0001628280-25-013103.md) | [1,385](/filings/0001628280-24-022320.md) | [1,349](/filings/0001628280-24-036346.md) | [1,349](/filings/0001628280-24-046441.md) | [1,314](/filings/0001628280-26-018160.md) | [1,308](/filings/0001628280-25-024748.md) | [1,341](/filings/0001628280-25-039595.md) | [1,336](/filings/0001628280-25-051077.md) | [1,271](/filings/0001628280-26-055246.md) | [1,251](/filings/0001628280-26-033481.md) | [1,333](/filings/0001628280-26-055246.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001628280-26-018160.md) | [19.4](/filings/0001628280-25-024748.md) | [21.1](/filings/0001628280-25-039595.md) | [21.1](/filings/0001628280-25-051077.md) | [696](/filings/0001628280-26-055246.md) | [702](/filings/0001628280-26-033481.md) | [702](/filings/0001628280-26-055246.md) |
| Short-term borrowings | $m | not reported | [98.1](/filings/0001628280-24-011316.md) | not reported | not reported | not reported | [0.0](/filings/0001628280-26-018160.md) | not reported | not reported | not reported | [696](/filings/0001628280-26-055246.md) | [702](/filings/0001628280-26-033481.md) | [702](/filings/0001628280-26-055246.md) |
| Shareholders' equity | $m | [559](/filings/0001628280-23-038961.md) | [633](/filings/0001628280-25-013103.md) | [641](/filings/0001628280-24-022320.md) | [654](/filings/0001628280-24-036346.md) | [683](/filings/0001628280-24-046441.md) | [670](/filings/0001628280-26-018160.md) | [593](/filings/0001628280-25-024748.md) | [611](/filings/0001628280-25-039595.md) | [635](/filings/0001628280-25-051077.md) | [553](/filings/0001628280-26-055246.md) | [539](/filings/0001628280-26-033481.md) | [451](/filings/0001628280-26-055246.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [25.2 d](/filings/0001628280-24-046441.md) | [33.7 d](/filings/0001628280-26-018160.md) | [21.5](/filings/0001628280-25-024748.md) | [46.4 d](/filings/0001628280-25-039595.md) | [10.7 d](/filings/0001628280-25-051077.md) | [39.7 d](/filings/0001628280-26-018160.md) | [15.4](/filings/0001628280-26-033481.md) | [6.5 d](/filings/0001628280-26-055246.md) | [22.6 d](/filings/0001628280-25-051077.md) | [20.6 d](/filings/0001628280-26-018160.md) | [40.0](/filings/0001628280-26-033481.md) | [(109) d](/filings/0001628280-26-055246.md) |
| Capital expenditure | $m | [12.4 d](/filings/0001628280-24-046441.md) | [15.1 d](/filings/0001628280-26-018160.md) | [14.5](/filings/0001628280-25-024748.md) | [15.4 d](/filings/0001628280-25-039595.md) | [12.5 d](/filings/0001628280-25-051077.md) | [15.1 d](/filings/0001628280-26-018160.md) | [15.7](/filings/0001628280-26-033481.md) | [16.1 d](/filings/0001628280-26-055246.md) | [14.7 d](/filings/0001628280-25-051077.md) | [13.0 d](/filings/0001628280-26-018160.md) | [16.1](/filings/0001628280-26-033481.md) | [13.8 d](/filings/0001628280-26-055246.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [323](/filings/0001628280-23-038961.md) | [409](/filings/0001628280-24-022320.md) | [397](/filings/0001628280-24-036346.md) | [400](/filings/0001628280-24-046441.md) | [415](/filings/0001628280-25-024748.md) | [414](/filings/0001628280-25-039595.md) | [410](/filings/0001628280-25-051077.md) | [412](/filings/0001628280-26-033481.md) | [414](/filings/0001628280-26-055246.md) | [415](/filings/0001628280-25-051077.md) | [418](/filings/0001628280-26-033481.md) | [420](/filings/0001628280-26-055246.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 421,018,476 at 2026-08-06, from the cover of the [10-Q filed 2026-08-10](/filings/0001628280-26-055246.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.